NotCo

NotCo is Latin America's leading alt-protein unicorn, and its real asset is not any single product but Giuseppe, the proprietary AI platform that maps the molecular and sensory profiles of animal foods and proposes plant-ingredient combinations to match them — a technology that turns NotCo into both a consumer brand (NotMilk, NotBurger, NotMayo, NotIceCream across the Americas) and a licensable B2B engine for incumbent food giants. That dual model is the differentiator: the 2022 joint venture with Kraft Heinz (The Kraft Heinz Not Company), now controlled by Kraft Heinz and led by NotCo's North America CEO, hands the marketing and distribution muscle of a global CPG to NotCo's AI, with management stating the JV is "on budget." NotCo raised a $235M Series D in 2021 (led by Tiger Global) at roughly a $1.5B valuation, taking total funding above $350M, and has since made hard restructuring decisions — an ~11% workforce cut and office closures in 2023-24 — to steer toward profitability. Its own-branded NotCo Foods business was on track to reach profitability as early as 2025 in its home markets (Chile, Argentina), and CEO Matias Muchnick has flagged possible group-level profitability near the end of 2026, plus a new GLP-1-oriented product tapping the metabolic-health wave. An AI ingredient-discovery platform monetized both as a brand and as licensed infrastructure is a genuinely differentiated position as the category rationalizes.

NotCo has repeatedly pushed back its profitability timeline — group-wide profitability slipped from 2024 to 2027 — and the ~11% layoffs and New York office closure in late 2023/early 2024 are the fingerprints of a company that raised at a 2021 peak valuation ($1.5B) and has been retrenching under it ever since. The Kraft Heinz joint venture, the centerpiece of the B2B thesis, has publicly "encountered challenges," and control sitting with Kraft Heinz means NotCo captures only a share of a venture whose direction it no longer sets. The consumer brands operate in plant-based milk and meat categories that are contracting across the Americas, with NotMilk fighting for shelf against Oatly, Silk, and private label in a segment where volumes have softened. Giuseppe is a compelling story, but "AI-formulated" is increasingly table stakes — incumbents and rivals all deploy computational formulation now, so the platform's licensing premium is eroding, and a B2B AI tool's value is only proven by recurring, scaled licensing revenue that NotCo has not clearly demonstrated. At above $350M raised against a valuation set in a very different market, a down-round is a live risk, and reaching even regional profitability by 2025 while group profitability waits until 2026-27 leaves years of continued burn. The pivot toward B2B AI and GLP-1 products reads partly as a search for a story that works after the consumer thesis stalled.